Last reviewed · How we verify
The Immunomodulatory Role of Vitamin D in Inflammatory Bowel Disease (The IBDVit Study): Double-Blind, Placebo-Controlled Trial of Adjuvant Vitamin D (Colecalciferol) With Corticosteroids in Active Crohn's Disease (IBDVit1)
The purpose of this study is to determine whether the addition of vitamin D to standard corticosteroids improves onset of remission in active Crohn's Disease, a form of Inflammatory Bowel Disease (IBD).
Details
| Lead sponsor | Imperial College London |
|---|---|
| Phase | Phase 4 |
| Status | WITHDRAWN |
| Start date | 2008-05 |
| Completion | 2010-05 |
Conditions
- Crohn's Disease
Interventions
- Colecalciferol D3 (Vigantol Oil)
- Medium chain triglycerides
Primary outcomes
- Clinical Remission (CDAI score <150) — 4 Weeks
Countries
United Kingdom